What Is Pseudomonas Aeruginosa and Why It’s Dangerous

Pseudomonas aeruginosa is a rod-shaped bacterium found in soil, water, and human-associated environments that ranks among the most dangerous hospital-acquired pathogens worldwide. It causes a range of infections from mild swimmer’s ear to fatal bloodstream sepsis, and it is particularly threatening because of its formidable natural resistance to antibiotics, its ability to form protective biofilms on surfaces and inside the body, and its arsenal of toxins that can rapidly destroy human cells. For healthy people, an encounter with it is usually harmless or produces a self-limiting infection. For hospitalized patients, people with compromised immune systems, burn victims, and those with cystic fibrosis, it can be deadly.

Where It Lives

You might read that Pseudomonas aeruginosa is “ubiquitous in the environment,” and that is technically true but misleading. A large study combining environmental sampling, genetic sequencing data, and a meta-analysis of published research found that while the bacterium can be detected in many habitats, it is actually scarce in pristine, undisturbed environments. It thrives in places closely linked with human activity, including contaminated soils, wastewater, hospital plumbing, and environments polluted with hydrocarbons or pesticides. It was also abundant in samples from humans and animals.¹ The practical takeaway: the bacterium is not equally distributed across nature. It clusters wherever people are, which is part of why it causes so many healthcare infections.

In hospitals, the germ colonizes wet surfaces readily. Sink drains, faucet aerators, shower heads, respiratory equipment, and even supposedly clean water lines have all been implicated in outbreaks. It tolerates a wide range of temperatures and nutrient conditions, and it can survive on dry surfaces longer than many other bacteria. This environmental persistence makes it extraordinarily difficult to eliminate from healthcare settings once it gains a foothold.

Its Toolkit for Attacking Cells

What makes Pseudomonas aeruginosa more dangerous than the average bacterium is the sheer number of weapons it carries. Rather than relying on one dominant toxin or one invasion strategy, it uses a layered attack that can be tailored to different tissues and different hosts.

One key weapon is exotoxin A, which shuts down protein production inside human cells. The toxin works by chemically modifying a molecule called elongation factor 2, which cells need to build new proteins. Once that molecule is disabled, the cell can no longer sustain itself and dies.² This mechanism is strikingly similar to how diphtheria toxin works, targeting the exact same site on the same molecule through an identical chemical reaction.³

Beyond exotoxin A, the bacterium has a type III secretion system, essentially a molecular syringe that punctures host cells and injects toxic proteins directly into them.⁴ One of the most aggressive toxins delivered this way is ExoU, which acts as a powerful membrane-destroying enzyme. Strains carrying ExoU cause rapid cell death by tearing apart cell membranes, and the toxin has been shown to be required for the bacterium to cause severe bloodstream infections in animal models.⁵⁶

The bacterium also produces pyocyanin, a vivid blue-green pigment that is partly responsible for the colored pus and wound drainage clinicians have associated with Pseudomonas infections for over a century. About 95% of Pseudomonas aeruginosa strains produce pyocyanin.⁷ Far from being just a colorful byproduct, pyocyanin damages host tissues by generating reactive oxygen species that stress and kill cells.⁸

How the Bacteria Coordinate Their Attack

Individual Pseudomonas aeruginosa cells are dangerous enough, but the bacterium becomes far more threatening once its population reaches a critical density. It uses a communication system called quorum sensing, in which individual cells release small signaling molecules into their surroundings. When enough bacteria are present and the concentration of these signals crosses a threshold, the entire population switches on the production of toxins, enzymes, and other virulence factors in a coordinated burst. The quorum-sensing network in Pseudomonas aeruginosa involves at least four interconnected signaling circuits that together regulate the expression of hundreds of genes.⁹¹⁰

This same communication system also controls biofilm formation, which is arguably the single most clinically important behavior of the bacterium.¹¹ Biofilms are structured communities of bacteria encased in a self-produced matrix of sugars and proteins. Once established, a biofilm dramatically changes the rules of engagement for both the immune system and antibiotics.

Biofilms and Why They Matter So Much

If you have heard that Pseudomonas aeruginosa infections are hard to treat, biofilms are a major reason. Bacteria living inside a biofilm are physically shielded from immune cells and from antibiotics that would easily kill them if they were free-floating. The matrix surrounding the cells acts as a barrier, slowing the diffusion of drugs and creating zones of low oxygen and low nutrient availability where the bacteria enter a dormant state that makes them even more tolerant of treatment.

In people with cystic fibrosis, Pseudomonas aeruginosa commonly converts to a “mucoid” form that overproduces a sugar polymer called alginate. Biofilms formed by these mucoid strains have a highly structured architecture and are significantly more resistant to antibiotics than biofilms formed by non-mucoid strains of the same genetic background.¹² This conversion to mucoidy is one of the hallmark adaptations the bacterium undergoes during chronic lung infections and is a sign to clinicians that a long-term, difficult-to-eradicate infection has taken hold.

Built-In Antibiotic Resistance

Many bacteria become resistant to antibiotics only after acquiring new genes through mutation or from other bacteria. Pseudomonas aeruginosa starts with an advantage: its outer membrane is naturally less permeable to many drugs than that of other common pathogens, and it constitutively runs efflux pumps that actively push antibiotics back out of the cell before they can reach their targets. The MexAB-OprM efflux system, for example, is always running and contributes to baseline resistance against multiple drug classes. Research has shown that knocking out this pump and increasing membrane permeability together produces the greatest improvement in antibiotic susceptibility, suggesting these two barriers work in concert.¹³

On top of this natural resistance, Pseudomonas aeruginosa can pick up additional resistance genes from its environment. A genomic analysis of the species found that genes encoding beta-lactamase enzymes, which break down penicillins and related antibiotics, are present in roughly 3% of all strains. That number sounds small until you look at carbapenem-resistant isolates specifically, where it jumps to about 35%. These acquired enzymes can confer resistance to carbapenems, cephalosporins, penicillins, and other beta-lactam drugs that represent some of the last-resort options for serious infections.¹⁴

Where It Causes the Most Harm

The infections Pseudomonas aeruginosa causes range widely in severity depending on who gets infected and where in the body the infection takes hold. The most dangerous clinical settings involve the lungs, the bloodstream, and large wounds.

Ventilator-Associated Pneumonia

In intensive care units, Pseudomonas aeruginosa is one of the most frequent causes of ventilator-associated pneumonia, the most common infection in ICU patients. It carries a high death rate even when treated appropriately, and outcomes worsen further when the infecting strain is multidrug-resistant.¹⁵ A systematic review and meta-analysis pooling data from over 7,900 cases across 16 countries found that about a third of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia were multidrug-resistant. The rates varied enormously by region, from roughly 20% in the United States to nearly 88% in Iran.¹⁶

Burn Wounds

Burn patients face an especially high risk. The loss of the skin barrier, combined with the protein-rich wound environment, creates ideal conditions for colonization. Burn wound sepsis is currently the main cause of illness and death after burn trauma, and infections by Pseudomonas aeruginosa are among the most severe, causing major delays in recovery or proving fatal.¹⁷ Researchers are actively investigating metabolic biomarkers in the blood that might allow earlier detection of Pseudomonas-caused sepsis in burn patients, since early intervention is critical to survival.¹⁸

Cystic Fibrosis

Chronic lung infection with Pseudomonas aeruginosa is a defining feature of cystic fibrosis. The thick, sticky mucus in CF airways creates an environment where the bacterium can establish itself and persist for years or decades. Over time, the bacterial population undergoes a striking evolutionary adaptation: it reduces production of many acute virulence factors, shifts to a biofilm-dominated lifestyle, and develops high-level antibiotic resistance. The population also diversifies, with different subpopulations within the same patient’s lungs showing different resistance profiles and different levels of toxin production. This diversity is dynamic, changing over time and making both diagnosis and treatment a moving target.¹⁹ Many of these adaptations, such as the mucoid conversion, increased mutation rates, and shifts in metabolism, occur repeatedly across different patients, suggesting the CF lung environment exerts strong and predictable selective pressures.²⁰

Cancer Patients

People undergoing cancer treatment, particularly those whose white blood cell counts have been driven down by chemotherapy, are highly vulnerable to Pseudomonas bloodstream infections. A large study of over 1,200 such episodes found that about a quarter were caused by multidrug-resistant strains, and that rate increased over the study period. Prior use of certain antibiotics, the presence of a urinary catheter, and having a blood cancer were all strong predictors of encountering a resistant strain.²¹

Mild Infections in Healthy People

For all its deadliness in vulnerable populations, Pseudomonas aeruginosa also causes infections in otherwise healthy people that are uncomfortable but rarely life-threatening. The two most common are swimmer’s ear and hot tub folliculitis.

Swimmer’s ear, an infection of the ear canal, has been repeatedly linked to swimming in water contaminated with the bacterium. In one well-documented outbreak, Pseudomonas aeruginosa was isolated from the ears of 18 out of 25 members of a competitive swim team who developed painful, discharging ears.²² Hot tub folliculitis occurs when inadequately disinfected warm water allows the bacterium to thrive and infect hair follicles, producing itchy red bumps across the torso and limbs. Outbreaks sometimes also involve ear infections and, less commonly, breast infections.²³ These community-acquired infections typically resolve on their own or with topical treatment, and they rarely progress to anything serious. The difference between a nuisance skin rash in a healthy swimmer and fatal sepsis in a burn patient is almost entirely about the state of the host’s defenses.

Its Place on Global Priority Lists

The World Health Organization maintains a priority pathogen list to guide antibiotic research and development. In the 2024 update, carbapenem-resistant Pseudomonas aeruginosa was reclassified from “critical” to “high” priority, a downgrade that reflects some observed decreases in resistance trends in at least one WHO region. The U.S. Centers for Disease Control and Prevention had already categorized it as “serious” rather than “critical” in their own 2019 threat report.²⁴ That said, the downgrade does not mean the problem is solved. The overall burden of resistant Pseudomonas aeruginosa remains a significant concern in certain populations and regions where resistance mechanisms are more prevalent. As the meta-analysis on ventilator-associated pneumonia showed, multidrug resistance rates vary wildly by country, and in some places the situation is getting worse, not better.

Why Hospital Disinfection Is So Tricky

Eliminating Pseudomonas aeruginosa from hospital environments is harder than it sounds. Not all disinfectants work equally well against it. A study of clinical isolates found that sodium hypochlorite at 5% concentration was the most effective disinfectant tested, while 70% ethanol was the least effective. Nearly all of the tested clinical isolates produced biofilm and carried efflux pump genes that could expel disinfectant chemicals, just as they expel antibiotics. More troubling, exposure to low concentrations of disinfectants actually altered the antibiotic resistance profiles of the bacteria, potentially worsening the resistance problem.²⁵ Quaternary ammonium compounds, a common class of hospital disinfectant, showed reduced effectiveness against a substantial proportion of multidrug-resistant clinical isolates in another study.²⁶ This creates a frustrating cycle: the same efflux pumps and biofilm-forming abilities that make the bacterium resistant to drugs also help it survive cleaning protocols.

Phage Therapy and Other Emerging Approaches

With conventional antibiotics increasingly failing against multidrug-resistant strains, researchers have turned to bacteriophages, viruses that naturally infect and kill bacteria. Phage therapy against Pseudomonas aeruginosa has shown particular promise because the bacterium’s biofilms, which are the hardest thing for antibiotics to penetrate, can be attacked from a different angle. Phages can destroy the biofilm matrix, increase the permeability of the biofilm to other treatments, and disrupt quorum sensing to prevent new biofilm formation.²⁷ Research has also shown that combining phages with antibiotics can enhance the killing effect beyond what either achieves alone.²⁸

Phage therapy is still far from routine clinical use for most patients, limited mainly to compassionate-use cases and a small number of clinical trials. But the logic is appealing: phages are highly specific to their bacterial targets, they replicate at the site of infection, and bacteria that evolve resistance to a phage sometimes lose antibiotic resistance in the trade-off. Combining phages with nanoparticles, enzymes, or natural antimicrobial compounds is an active area of investigation as well.

A Pathogen That Infects Across Kingdoms

One of the more unusual things about Pseudomonas aeruginosa is that it does not limit itself to human hosts. The same strain can infect plants, insects, nematodes, and mammals using overlapping sets of virulence tools. Researchers demonstrated this directly by screening mutant strains for reduced ability to infect plant leaves, then testing those same mutants in a burned-mouse infection model. Nine out of nine mutants that were less pathogenic in plants were also significantly less pathogenic in mice, suggesting the bacterium uses a shared set of strategies across very different hosts.²⁹ Further work confirmed that the overlap extends to nematodes and insects as well, though some virulence genes matter more in one host than another.³⁰

This cross-kingdom pathogenicity is rare among bacteria and speaks to the extraordinary versatility of Pseudomonas aeruginosa’s virulence machinery. It also has a practical research upside: plant and invertebrate infection models can be used as faster, cheaper screening tools to identify virulence factors and test potential treatments before moving to mammalian studies.³¹ The wax moth larva, the tiny roundworm C. elegans, and lettuce leaves have all served as stand-ins for studying how this bacterium causes disease, an unusual honor for a pathogen that most people encounter, if ever, as a greenish tinge on old bandages or a sore ear after a swim.